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Abstract
Background
Heart Failure (HF) is a primary diagnosis for hospital admission in adults from the Emergency
Department (ED), but not all patients require hospitalization. Emergency Heart Failure Mortality
Risk Grade (EHMRG) is designed to estimate mortality in patients with acute HF in ED settings.
Objectives
To risk-stratify patients with acute HF using EHMRG scores and assess patient safety.
Methods
Retrospective cohort analysis of 304 patients with acute HF presenting to an ED at a large
tertiary healthcare center. EHMRG scores were calculated per previous thresholds. Mortality
and Major Adverse Cardiac Event (MACE) rates were analyzed.
Results
EHMRG risk group respective seven-day mortality rates 0.0% in very low and low-risk groups.
Mortality and MACE rates are significantly less in lower-risk groups at 30 days.
Conclusions
ED risk stratification with EHMRG has the potential to revolutionize care for patients with acute
HF. Lower-risk patients may be safely discharged or treated in ED observation units (EDOUs).

Keywords: Heart Failure, Emergency Department, Emergency Heart Failure Mortality Risk
Grade (EHMRG), Mortality, Risk stratification, Emergency Department Observation Unit
(EDOU)
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1

Introduction

2

Heart Failure (HF) affects an estimated 6.2 million adults in the United States (US) and

3

prevalence is increasing.1 It is projected by 2050, that one in five people over the age of 65 will

4

be diagnosed with HF.2 Patients with acute HF often present to the Emergency Department (ED)

5

to access care and more than 80% of these patients are admitted to the hospital.3 HF is a leading

6

cause of costly hospital admissions in adults greater than 65 years of age; however, up to 50% of

7

hospital admissions for HF may not be required.4 5 For patients diagnosed with HF, the age-

8

adjusted all-cause mortality rate is tripled in comparison to patients without HF, yet this

9

mortality risk is difficult for ED providers to quantify.8 9 However, select patients with acute HF

10

may be considered for direct discharge or management in an ED observation unit (EDOU) as an

11

alternative option for care.6

12

EDOUs were created to care for patients that need further observation and/or treatment, but do

13

not necessarily require admission to the hospital.6 Common cardiac diagnoses managed in

14

EDOUs include, chest pain, atrial fibrillation (AF), syncope, and lower risk patients with acute

15

HF, as described in the literature.6 9 Risk stratification in the form of an objective tool is a

16

approach to assess patients in the ED with acute HF, to identify lower-risk patients that may be

17

appropriate for further care in EDOUs.6

18

Emergency Heart Failure Mortality Risk Grade (EHMRG), a prospectively and externally

19

validated risk stratification tool (RST), was developed specifically for patients with acute HF that

20

present to ED settings.7 Patients with acute HF are stratified with EHMRG into five risk groups

21

according to projected seven-day mortality.7 EHMRG was first assessed in 2012 with a

22

derivation cohort of nearly 7500 patients and a validation cohort of approximately 5000 patients

23

from 86 hospitals in Ontario, Canada.7 Associated seven-day mortality in the risk groups was
4
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24

reported as 0.3% (lowest risk), 0.3% (low risk), 0.7% (intermediate), 1.9% (high), 3.5% (very

25

high A), and 8.2% (very high B) risk groups.7 In 2019, the ACUTE study was completed as

26

prospective validation of EHMRG scores in nine hospitals in Ontario, Canada.9 With

27

prospective validation, seven-day mortality rates were reported as 0.0%, 0.0%, 0.6%, 1.9%, and

28

3.9% for the five risk groups respectively.9 It was determined that patients in lower-risk

29

categories may be more appropriate for direct discharge from the ED or EDOU management.6 9

30

Although the mortality risk associated with acute HF intensifies patient management, EHMRG is

31

designed to enhance disposition planning in the ED to promote informed decisions.9

32

Establishing mortality risk, in conjunction with early, aggressive treatment, may lead to

33

improved management for patients with acute HF who present to the ED setting. 6 9 Combined

34

with early post-discharge care, EHMRG can identify lower-risk patients that may be appropriate

35

for discharge or management in an EDOU, as an alternative to hospital admission. The purpose

36

of this study is to risk-stratify patients with acute HF using EHMRG scores in an ED in the

37

United States (US), while assessing patient outcomes.

38

Methods

39

A retrospective cohort analysis was conducted at a large Midwestern tertiary healthcare center to

40

assess the use of EHMRG scores. The study sought to determine, in patients who present to the

41

ED with acute HF, do EHMRG scores, compared to not using EHMRG scores, appropriately risk

42

stratify patients to be treated in the EDOU without compromising patient safety, during a one-

43

year retrospective study period? Institutional review board (IRB) review was sought at the

44

healthcare institution and collaborating university. The project was deemed IRB exempt,

45

minimal risk to human subjects, from by both institutions.
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46

Patients presenting to the ED, from January 1, 2020 to December 31, 2020, with a diagnosis of

47

acute HF were reviewed. Each patient ED visit for acute HF was included in the cohort study;

48

therefore, some patients had multiple ED visits in the study period. More than 340 patient visits,

49

as identified by the International Classification of Diseases, Tenth Revision (ICD-10) codes for

50

heart failure, were reviewed. ICD-10 codes used for data extraction included, 150.2, 150.21,

51

150.22, 150.23, 150.31, 150.33, 150.41, 150.43, 150.811, 150.813, and 150.9. Patients with a

52

missing variable were excluded as the EHMRG score could not be calculated. Patients without a

53

primary diagnosis of acute HF, and those actively receiving dialysis or those enrolled in

54

palliative care management were excluded, as previously described as exclusion criteria.7 A

55

patient research authorization was required to use patient data.

56

Patient characteristics and variables were extracted from the study cohort. A total of 10 variables

57

deemed predictors of HF mortality in the ED are required to calculate EHMRG scores including,

58

age, transported by EMS, triage systolic blood pressure, triage heart rate, triage oxygen

59

saturation, creatinine, potassium, troponin greater than the upper limit of normal (ULN), active

60

cancer, and metolazone use (a marker of diuretic resistance).7 A clinician and trained study

61

coordinator entered variables into a Research Electronic Data Capture (REDCap) database

62

provided by the healthcare institution. REDCap is a secure, web-based software platform

63

created to store and manage data collected for research.10 11 A clinician manually reviewed

64

electronic health records (EHR) regarding each patient visit to determine if patients met

65

inclusion criteria for the cohort study. Additionally, any elevation of troponin was reviewed by

66

a clinician to determine clinical significance in the setting of acute HF, in accordance with

67

clinical use of high sensitivity troponins at the healthcare center.
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68

Patients were categorized into five groups according to estimated mortality risk, from very low

69

to very high risk, according to EHMRG thresholds defined in the original derivation/validation

70

study.7 EHMRG risk groups are defined as very low (scores less than or equal to - 49.1), low

71

(scores - 49.0 to - 15.9), intermediate (scores - 15.8 to 17.9), high (scores 18.0 to 56.5), and very

72

high-risk (scores 56.6 or greater). The very high risk group was further divided into A (scores

73

56.6 to 89.3) and B (scores greater than or equal to 89.4) subgroups to appreciate the B

74

subgroup’s extreme mortality risk.7

75

Patient Outcomes as Measures of Safety

76

Assessment of EHMRG scores in relation to patient outcomes measures were analyzed to

77

determine safety. Mortality rates and Major Adverse Cardiac Event (MACE) rates at seven and

78

30 days post-discharge were obtained for each patient in the study cohort. In this cohort study,

79

MACE rates were defined as acute myocardial infarction (MI); cardiac arrest; coronary

80

revascularization via coronary artery bypass grafting (CABG), stent, or percutaneous coronary

81

intervention (PCI); stroke; hospitalization for acute HF; and return to the ED for acute HF.

82

MACE event rates were extracted by ICD-10 codes.

83

Statistical Analyses

84

Continuous features are summarized with medians and interquartile ranges (IQRs); categorical

85

features are summarized with percentages. The frequency of patient mortality and MACE events

86

at seven and 30 days were compared between EHMRG risk groups using odds ratios (ORs) and

87

Wald’s tests. For groups with zero outcomes, ORs were computed using the Haldane-Anscombe

88

correction to avoid issues when dividing by zero.
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89

The observed seven and 30-day mortality rate for each EHMRG risk group in this study was

90

compared to mortality rates using pairwise Chi-squared and Fisher’s exact tests. All tests were

91

two-sided, and p-values less than 0.05 were considered significant.

92

Results

93

The final study cohort was comprised of 304 patients. All participants were evaluated in the ED

94

with a primary diagnosis of acute HF, at the tertiary health care center, during the one-year

95

timeframe.

96

Cohort Characteristics

97

The study cohort had a median age of 77.5 years. Males comprised 53.6% of the study cohort,

98

whereas females were 46.4%. Within the study cohort, race was described as 94.7% White and

99

5.3% Asian, Black/African American, or Other/Did Not Disclose. Details of ethnicity included

100

99% not Hispanic or Latino, and 1% Other. The median left ventricular ejection fraction was

101

50% (Table 1).

102

EHMRG Risk Groups

103

The median EHMRG score for the study cohort was 15.0. Within the study cohort, 12.8% of

104

patients were very low-risk (median score of -71.0);18.8% low-risk (median score of -33.0);

105

20.1% intermediate risk (median score of 1.0); 19.1% high-risk (median score of 37.0); and

106

29.2% very high-risk. The very high group was further subdivided into very high A at 15.1%

107

(median score 74.0) and very high B at 14.1% (median score of 119.0) in Table 1. Table 2

108

details variables of EHMRG scores by EHMRG risk groups.

109

Cohort Hospitalization and Discharge Rates
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110

In the study cohort, more than 87% of patients with acute HF were admitted to the hospital.

111

Whereas 8.6% of patients with acute HF were discharged from the ED. Patients with acute HF

112

managed in the EDOU comprised 2.6% of the study cohort (Table 1).

113

Mortality and MACE Rates

114

Seven-day mortality rates in the very low and low-risk EHMRG risk groups were 0.0%. More

115

than 90% of patient deaths within seven days post-discharge from the ED were in the very high

116

A or very high B EHMRG risk groups. Mortality rates at 30 days were lowest in the very low

117

and low risk groups. 77% of patient deaths within 30 days post-discharge from the ED were in

118

the high and very high EHMRG risk groups. A linear increase in MACE event rates is reflected

119

at seven days for all EHMRG risk groups, with the least number of events in the lowest EHMRG

120

risk groups. Whereas MACE rates at 30 days for any event were lowest in the very low risk

121

group. The results reflect a predominantly upward trend in MACE events as risk increases

122

between the lower and higher risk groups, supporting that EHMRG scores can risk stratify for

123

mortality and MACE events. Overall, lower risk EHMRG groups have lower mortality rates and

124

less MACE events.

125

A comparison of EHMRG risk groups was completed. The highest EHMRG risk groups (very

126

high A and B) have 27.1 times greater odds of seven-day mortality when compared to the other

127

groups (95% CI 3.4 – 215.1, p = .002), and 3.76 times greater odds of 30-day mortality when

128

compared to all other groups (95% CI 1.65 – 8.55, p = .002). Whereas the very low and low risk

129

EHMRG groups have 74% decreased odds of experiencing 30-day mortality (OR 0.26, 95% CI

130

0.08 – 0.89, p = .031). The very low-risk EHMRG group also has a 60% decrease in odds of 30-

131

day MACE events compared to all other risk groups (OR 0.40, 95% CI 0.16 – 0.99, p = .047).

132

Discussion
9
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133

The retrospective cohort study explores the utility of EHMRG scores within an ED in a large

134

Midwestern tertiary healthcare center within the US. The project’s importance is to obtain

135

baseline clinical data to translate the use of EHMRG scores to clinical practice. Moreover, the

136

association of mortality and MACE rates with EHMRG groups provides perspective toward

137

future clinical use of EHMRG scores when determining the appropriate disposition for patients

138

who present to the ED with acute HF.

139

Opportunity for EDOU Management

140

Consistent with the literature, 87.2% of patients in this cohort with acute HF in the ED at this

141

healthcare center were admitted to the hospital. 3 However, 8.6% of patients with acute HF were

142

discharged from the ED at this health care center which is lower than the average percentage of

143

16.3% reported at other US institutions.12 The number of patients with acute HF admitted to the

144

EDOU is minimal at 2.6%. All patients admitted to the EDOU were representative of the very

145

low or low-risk groups, except one patient was from the intermediate risk group. Patients in the

146

very low and low-risk groups comprise 31.6% of the study cohort; therefore, the potential for

147

increased utilization of the EDOU to treat appropriate patients is an option. Associated seven-

148

day mortality was 0.0% for both lower-risk groups. MACE rates were lowest in the very low

149

and low groups at seven days post-discharge, supporting patient safety in lower-risk groups.

150

Although some patient’s scores may fit in the lower-risk EHMRG groups, clinical judgment

151

from the emergency medicine or cardiology providers exceeds risk scores when determining if

152

individual patients require hospital admission over management in an EDOU. It has been

153

described that approximately 20% of patients managed in EDOUs may require hospital

154

admission due to inadequate response to treatment or worsening clinical features necessitating

155

hospital admission.13 Patients with acute HF that exhibit high-risk features; cardiac ischemia or
10
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156

arrhythmias; unstable hemodynamics; worsening comorbidities like renal dysfunction,

157

hyponatremia, or exacerbations of other disease processes; require hospital admission.13

158

Ultimately, the purpose of the EDOU is to identify changes in patient clinical status that warrant

159

further investigation that may include hospitalization.

160

Limitations

161

There are several limitations to this retrospective analysis. First, the study cohort may not

162

represent the entire population of patients presenting to the ED with acute HF at the healthcare

163

center. Although the data were extracted according to ICD-10 codes, some patients may have

164

been coded incorrectly. It is also possible that some patients with acute HF were not captured

165

with the selected ICD-10 codes.

166

Another limitation was the patient cohort was reviewed by a clinician who manually entered data

167

to calculate EHMRG scores. While this process provides consistency in using EHMRG scores,

168

the interpretation was also limited by the clinician’s judgment. Furthermore, an error in data

169

entry could have occurred.

170

The retrospective review was restricted to one-year with approximately 300 patients. Although

171

this provides baseline data to validate EHMRG scores in this study cohort in the US, a larger

172

analysis is more desirable to obtain results that reflect a larger population of HF patients over an

173

extended time. Lastly, the study cohort was quite homogeneous, as evidenced by race/ethnicity

174

statistics from this Midwestern healthcare center. Overall, a larger, more diverse population is

175

needed to further validate EHMRG scores in ED settings in the US.

176

Clinical Implications

177

EHMRG scores may be easily calculated as most of the variables are obtained through VS

178

during triage, during patient history, or obtaining typical laboratory tests in the ED. However,
11
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179

several common themes emerged during this analysis (Table 3). When patients are transported

180

via EMS, an upload of initial VS in the EHR may be delayed. Access to the initial VS from

181

EMS would improve the accuracy of this data. A process to obtain triage VS is essential for the

182

clinical use of EHMRG, as it is recommended that initial triage VS should be used when

183

available for the most accurate scores. 7

184

The second theme identified that troponin values were not routinely drawn in every patient in

185

acute HF as part of the laboratory assessment. Several patients were excluded in the

186

retrospective review due to a missing troponin value. Further education of providers to obtain a

187

baseline troponin values may improve the ability to calculate additional EHMRG scores.

188

A third theme is evolution of high sensitivity cardiac troponins (hs-cTnTs). At this healthcare

189

center, the specific hs-cTnT assay was chosen for its accuracy in the evaluation of myocardial

190

injury/infarction. 14 Although hs-cTnT is extremely sensitive for myocardial injury, it has been

191

established that troponin elevation may be present due to various cardiac and non-cardiac

192

reasons including HF, which is not determined by this test. 15 At this healthcare center an

193

established protocol, which is known to the ED practice, using serial hs-cTnTs exists for

194

evaluation of patients with elevated initial value. Serial hs-cTnT values are drawn at baseline,

195

two hours, and six hours, while a delta change is calculated between samples. Elevation of serial

196

troponins without a significant delta change were commonly seen in this study cohort of patients

197

with acute HF. It was observed that nearly all patients in this study cohort had an elevation in

198

hs-cTnT above the 99% percentile; however, this was reflective of chronic myocardial injury

199

rather than an acute cardiac event. Therefore, according to the healthcare centers standard of

200

practice, the majority of patients in the study cohort required a baseline and two-hour troponin,

201

with an associated delta, to determine clinical significance in the setting of acute HF. An
12
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202

algorithm to decipher low, intermediate, and high-risk hs-cTnT thresholds is already established.

203

Delta change between serial troponin values, plus assessment of 12 lead electrogram (ECG), is

204

defined to determine if the myocardial injury is acute. 14 Although no distinct thresholds for hs-

205

cTnT have been established to reflect acute HF mortality, a well-defined algorithm has been

206

designed for clinical use, which was followed to establish the clinical significance of troponin

207

values for calculating EHMRG scores.

208

Patients with advanced stage three, four, or five chronic kidney disease (CKD), not receiving

209

dialysis, often have elevations in hs-cTnTs that are well above the 99% percentile, without

210

associated ischemic changes on 12 lead ECG or significant delta change in serial troponins. It

211

has been established that patients with stable chronically elevated troponin levels without

212

significant rise and fall between serial samples, exhibiting chronic hs-cTnT elevations greater

213

than the 99th percentile, are most commonly associated with diagnoses of structural heart disease

214

and/or chronic kidney disease. 16 Elevated hs-cTnT is associated with increased mortality;

215

however, reasonable thresholds for hs-cTnT values in patients with advanced CKD are not

216

clearly defined. More research is needed to quantify appropriate hs-cTnT cut-offs associated

217

with mortality risk in patients with acute HF and CKD.

218

The final theme noted was that many patients are admitted with multifactorial dyspnea, including

219

acute HF. Some patients may have associated pneumonia, COPD exacerbation, or atrial

220

fibrillation, in addition to acute HF. Because they are all treated as potential causes of dyspnea,

221

it may be unclear which diagnosis was of greater importance clinically.

222

In summary, these themes were identified during the retrospective analysis. Further clarification

223

of the use of hs-cTnT with EHMRG will be help improve standardization when using EHMRG

224

scores clinically.
13
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225

Thresholds for Adverse Events

226

Thresholds for adverse event rates in patients treated in EDOUs for acute HF are recommended.

227

Specifically, it is described EDOUs should aim to achieve a 30-day mortality rate of less than

228

2%, a seven-day ED revisit rate of less than 10%, and a 30-day ED/hospital revisit rate of less

229

than 20% per expert opinion.12 Patients in the lower EHMRG risk groups had associated seven-

230

day mortality rates of 0.0%, which was also shown in the ACUTE study in 2019.9 Mortality in

231

the very high B group was much higher, which perhaps reflects the severe acuity of the highest

232

risk group at this healthcare center. There were several patients in the highest risk groups that

233

discharged from the hospital with hospice care that had anticipated mortality events within the

234

next seven to 30 days. This may also reflect cultural differences in end of life care in different

235

countries. Overall, a larger sample size for validation of these results is needed.

236

Publicly reported 30-day mortality rates for heart failure are benchmarked 11.3%.17 The study

237

cohort had a 30-day mortality rate of 8.6%, similar to the respective publicly reported rate at

238

9.1% at this health care center.17 MACE rates were an addition to this study in an attempt to

239

further clarify patient safety measures. Return ED visits rates at seven days was below the

240

recommended threshold of 10%.12 Thirty-day return to the ED visit rates were below the

241

recommended 20%, whereas 30-day rehospitalization for HF rates were slightly higher than the

242

recommended threshold of 20%. 12

243

Conclusion

244

Risk stratification with EHMRG was easily applied to a retrospective clinical population in an

245

ED at a large Midwestern tertiary healthcare center in the US. The application of EHMRG at this

246

healthcare center shows that mortality rates for lower EHMRG risk groups are similar to other

247

studies. MACE rates in the study cohort were added as an additional measure of patient safety
14

Risk stratification for acute heart failure in the emergency department

248

which were consistent with the literature reflecting expert opinion and publicly available

249

measures. Although the study cohort is a smaller sample and lacks generalizability to all patients

250

with acute HF, results reflect that appropriate lower-risk patients, as stratified by EHMRG, have

251

the potential to be safely managed in EDOUs. Furthermore, establishing specific inclusion/

252

exclusion criteria for EDOU, criteria for admission to the hospital or discharge home, and early

253

follow-up care, is essential for this model of care to reduce unnecessary hospital admissions.

254

Validation of mortality and MACE event rates in a larger sample of more diverse patients is

255

recommended. Overall, clinical use of EHMRG should be considered as an automated process

256

as a way to reduce hospital admissions and shift care to supportive outpatient environments for

257

lower-risk patients.

258

Further research is also needed to determine safety with using hs-cTnT values to accurately

259

reflect patient’s seven-day mortality risk in acute HF and CKD. Although hs-cTnT is very

260

sensitive and found to be elevated in multiple cardiac and non-cardiac conditions, it is also

261

highly predictive of patient mortality.15 Distinguishing thresholds for EHMRG risk groups will

262

provide more accurate and replicable use of EHMRG in future studies.
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Appendices

Table 1. Cohort Characteristics

Sex
Male
Female
Age – Median [IQR]
Race
Asian
Black/African American
Other/Did Not Disclose
White
Ethnicity
Not Hispanic or Latino
Other
LVEF Percent – Median [IQR]
EHMRG Score – Median [IQR]
EHMRG Risk Group
Very Low Risk
Low Risk
Intermediate Risk
High Risk
Very High Risk A
Very High Risk B
ED Disposition
Admitted
Discharged
ED Observation Unit
Left Before Treatment/AMA

53.6%
46.4%
77.5 [70.0, 84.2]
5.3%

94.7%
99.0%
1.0%
50.0 [32.0, 61.0]
15.0 [-28.0, 69.2]
12.8%
18.8%
20.1%
19.1%
15.1%
14.1%
87.2%
8.6%
2.6%
1.6%

IQR = Interquartile Range; LEVF = Left Ventricular Ejection
Fraction; EHMRG = Emergency Heart Failure Risk Grade.
ED = Emergency Department; AMA = Against Medical Advice
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Table 2. EHMRG Variables by Risk Category
EHMRG Risk Category

Age
Arrival by
EMS
SBP
Heart Rate
Oxygen
Saturation
Creatinine
Potassium
< 4 mmol/L
4-4.5 mmol/L
> 4.5 mmol/L
Troponin
> ULN
Active
Cancer
Metolazone
at Home
EHMRG
Score

Very Low

Low

Intermediate

High

Very High
A

Very High
B

66 [58, 75]

74 [67, 80]

80 [70, 85]

77 [71, 84]

80 [75, 87]

83 [78, 91]

3%

12%

25%

47%

65%

79%

157
[142, 175]
70
[65, 86]
96
[93, 97]
1.04
[0.91-1.24]

141
[126, 153]
80
[65, 92]
96
[94, 97]
1.06
[0.88, 1.24]

139
[123, 153]
77
[70, 91]
96
[93, 98]
1.13
[1.02, 1.53]

31%
59%
10%

28%
51%
21%

33%
38%
30%

22%
40%
38%

17%
44%
39%

19%
21%
61%

0%

2%

15%

30%

39%

58%

0%

4%

7%

7%

15%

30%

0%

2%

8%

9%

15%

26%

-71
[-83, -64]

-33
[-42, -23]

1
[-7, 10]

37
[27, 48]

74
[66, 84]

119
[104, 150]

130
135
122
[117, 153] [117, 153] [110, 143]
82
83
81
[66, 98]
[70, 87]
[68, 98]
96
95
96
[94, 98]
[90, 97]
[93, 97]
1.42
1.56
1.91
[1.08, 2.09] [1.24, 2.13] [1.32, 2.56]

EHMRG = Emergency Heart Failure Mortality Risk Grade; EMS = Emergency Medical Services; SBP =
Systolic Blood Pressure; ULN = Upper Limit Normal
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Table 3. Common Themes with EHMRG Scores
Common Themes
1. Timely and accurate triage vital signs
2. Missing troponin variable
3. Use of high-sensitivity troponins in acute HF and advanced CKD
4. Multifactorial dyspnea in the setting of acute HF
HF = Heart Failure; CKD = Chronic Kidney Disease
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